Germany
Germany

Time filter

Source Type

— In this report, the global Perfume Packaging market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Perfume Packaging in these regions, from 2012 to 2022 (forecast), covering North America Europe China Japan Southeast Asia India For more information or any query mail at sales@wiseguyreports.com Global Perfume Packaging market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including Rexam Silgan Holding Heinz HCP Gerresheimer Albea Group Amcor SABIC IP Dejin Plastic Packaging RPCGroup Yifang Packaging Shenda Cosmetic Pack Jinuo Glass Sanxing On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into Glass Plastic Other On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Perfume Packaging for each application, including Main Container Auxiliary Material If you have any special requirements, please let us know and we will offer you the report as you want. Global Perfume Packaging Market Research Report 2017 1 Perfume Packaging Market Overview 1.1 Product Overview and Scope of Perfume Packaging 1.2 Perfume Packaging Segment by Type (Product Category) 1.2.1 Global Perfume Packaging Production and CAGR (%) Comparison by Type (Product Category) (2012-2022) 1.2.2 Global Perfume Packaging Production Market Share by Type (Product Category) in 2016 1.2.3 Glass 1.2.4 Plastic 1.2.5 Other 1.3 Global Perfume Packaging Segment by Application 1.3.1 Perfume Packaging Consumption (Sales) Comparison by Application (2012-2022) 1.3.2 Main Container 1.3.3 Auxiliary Material 1.4 Global Perfume Packaging Market by Region (2012-2022) 1.4.1 Global Perfume Packaging Market Size (Value) and CAGR (%) Comparison by Region (2012-2022) 1.4.2 North America Status and Prospect (2012-2022) 1.4.3 Europe Status and Prospect (2012-2022) 1.4.4 China Status and Prospect (2012-2022) 1.4.5 Japan Status and Prospect (2012-2022) 1.4.6 Southeast Asia Status and Prospect (2012-2022) 1.4.7 India Status and Prospect (2012-2022) 1.5 Global Market Size (Value) of Perfume Packaging (2012-2022) 1.5.1 Global Perfume Packaging Revenue Status and Outlook (2012-2022) 1.5.2 Global Perfume Packaging Capacity, Production Status and Outlook (2012-2022) 2 Global Perfume Packaging Market Competition by Manufacturers 2.1 Global Perfume Packaging Capacity, Production and Share by Manufacturers (2012-2017) 2.1.1 Global Perfume Packaging Capacity and Share by Manufacturers (2012-2017) 2.1.2 Global Perfume Packaging Production and Share by Manufacturers (2012-2017) 2.2 Global Perfume Packaging Revenue and Share by Manufacturers (2012-2017) 2.3 Global Perfume Packaging Average Price by Manufacturers (2012-2017) 2.4 Manufacturers Perfume Packaging Manufacturing Base Distribution, Sales Area and Product Type 2.5 Perfume Packaging Market Competitive Situation and Trends 2.5.1 Perfume Packaging Market Concentration Rate 2.5.2 Perfume Packaging Market Share of Top 3 and Top 5 Manufacturers 2.5.3 Mergers & Acquisitions, Expansion 7 Global Perfume Packaging Manufacturers Profiles/Analysis 7.1 Rexam 7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 7.1.2 Perfume Packaging Product Category, Application and Specification 7.1.2.1 Product A 7.1.2.2 Product B 7.1.3 Rexam Perfume Packaging Capacity, Production, Revenue, Price and Gross Margin (2012-2017) 7.1.4 Main Business/Business Overview 7.2 Silgan Holding 7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 7.2.2 Perfume Packaging Product Category, Application and Specification 7.2.2.1 Product A 7.2.2.2 Product B 7.2.3 Silgan Holding Perfume Packaging Capacity, Production, Revenue, Price and Gross Margin (2012-2017) 7.2.4 Main Business/Business Overview 7.3 Heinz 7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 7.3.2 Perfume Packaging Product Category, Application and Specification 7.3.2.1 Product A 7.3.2.2 Product B 7.3.3 Heinz Perfume Packaging Capacity, Production, Revenue, Price and Gross Margin (2012-2017) 7.3.4 Main Business/Business Overview 7.4 HCP 7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 7.4.2 Perfume Packaging Product Category, Application and Specification 7.4.2.1 Product A 7.4.2.2 Product B 7.4.3 HCP Perfume Packaging Capacity, Production, Revenue, Price and Gross Margin (2012-2017) 7.4.4 Main Business/Business Overview 7.5 Gerresheimer 7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 7.5.2 Perfume Packaging Product Category, Application and Specification 7.5.2.1 Product A 7.5.2.2 Product B 7.5.3 Gerresheimer Perfume Packaging Capacity, Production, Revenue, Price and Gross Margin (2012-2017) 7.5.4 Main Business/Business Overview 7.6 Albea Group 7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 7.6.2 Perfume Packaging Product Category, Application and Specification 7.6.2.1 Product A 7.6.2.2 Product B 7.6.3 Albea Group Perfume Packaging Capacity, Production, Revenue, Price and Gross Margin (2012-2017) 7.6.4 Main Business/Business Overview 7.7 Amcor 7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 7.7.2 Perfume Packaging Product Category, Application and Specification 7.7.2.1 Product A 7.7.2.2 Product B 7.7.3 Amcor Perfume Packaging Capacity, Production, Revenue, Price and Gross Margin (2012-2017) 7.7.4 Main Business/Business Overview 7.8 SABIC IP 7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 7.8.2 Perfume Packaging Product Category, Application and Specification 7.8.2.1 Product A 7.8.2.2 Product B 7.8.3 SABIC IP Perfume Packaging Capacity, Production, Revenue, Price and Gross Margin (2012-2017) 7.8.4 Main Business/Business Overview 7.9 Dejin Plastic Packaging 7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 7.9.2 Perfume Packaging Product Category, Application and Specification 7.9.2.1 Product A 7.9.2.2 Product B 7.9.3 Dejin Plastic Packaging Perfume Packaging Capacity, Production, Revenue, Price and Gross Margin (2012-2017) 7.9.4 Main Business/Business Overview For more information or any query mail at sales@wiseguyreports.com ABOUT US: Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of rmaket research reports under these categories and sub-categories. For more information, please visit https://www.wiseguyreports.com


News Article | May 4, 2017
Site: www.prnewswire.com

Factors such as increasing demand for different-sized packs and growing focus on packaging as a significant tool for brand differentiation are favouring the growth of the PET packaging market. Moreover, growth in sectors such as food, beverage, personal care, and pharmaceutical, and rise in demand of sustainable & recyclable packaging is fueling the market. The emerging economies of Asia Pacific and Latin America hold a great potential for the PET packaging market. Volatility in raw material prices is hampering the PET packaging market. Bottles & jars are highly chosen due to recyclability, ease and flexibility. PET packaging is ideal in the food industry because it preserves the freshness of food items and extends the shelf life. Asia-Pacific region is expected to grow at a faster pace owing to less labor costs, tremendous industrialization, a vast scope for FDI, and emerging economic conditions. Some of the key players in the market include Smurfit Kappa Group PLC, Rexam PLC, Resilux NV, Klöckner Pentaplast GmbH & Co. Kg, Huhtamaki Group, GTX Hanex Plastic Sp.Z O.O., Graham Packaging Company, Gerresheimer AG, E. I. Du Pont De Nemours and Company (Dupont), Dunmore, CCL Industries, Inc., Berry Plastics Group Inc. and Amcor Limited. Regions Covered: - North America o US o Canada o Mexico - Europe o Germany o France o Italy o UK o Spain o Rest of Europe - Asia Pacific o Japan o China o India o Australia o New Zealand o Rest of Asia Pacific - Rest of the World o Middle East o Brazil o Argentina o South Africa o Egypt What our report offers: - Market share assessments for the regional and country level segments - Market share analysis of the top industry players - Strategic recommendations for the new entrants - Market forecasts for a minimum of 6 years of all the mentioned segments, sub segments and the regional markets - Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations) - Strategic recommendations in key business segments based on the market estimations - Competitive landscaping mapping the key common trends - Company profiling with detailed strategies, financials, and recent developments - Supply chain trends mapping the latest technological advancements About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/pet-packaging---global-market-outlook-2016-2022-300451886.html


Receive press releases from iHealthcareAnalyst, Inc.: By Email Global Disposable Syringes Market Analysis: Products, Growth Trends and Forecast to 2020, New Research by iHealthcareAnalyst, Inc. Disposable Syringes Market by Syringe Types (Safety Syringes – Automatic Syringes and Manual Retractable Syringes, Non-Retractable Syringes; and Conventional Syringes – With or Without Needles) 2016-2020 Maryland Heights, MO, February 17, 2017 --( Browse Disposable Syringes Market by Syringe Types (Safety Syringes – Automatic Syringes and Manual Retractable Syringes, Non-Retractable Syringes; and Conventional Syringes – With or Without Needles) 2016-2020 report at https://www.ihealthcareanalyst.com/report/disposable-syringes-market/ Globally, disposable syringes are more popular than re-usable syringes, primarily due to cost, accuracy, sterility, and ease of handling. Syringes equipped with safety mechanisms are known as safety syringes. Safety syringes protect patients and health care professionals from accidental needlestick injuries. Disposable Syringes with wide market potential are being used for intravenous or intramuscular injections and are fast replacing the age-old glass syringes due to their availability in sterilized condition, ready to use, and cost effectiveness. Disposable syringes are the most sold medical devices in the world. An estimated 39,000 million units are sold annually, with market value of approximately USD 4,935.8 million. The global disposable syringes market report provides market size estimates (Revenue USD million - 2013 to 2020) for key market segments based on the syringe type (safety syringes – automatic and manual retractable, non-retractable syringes; and conventional syringes either with or without needles), and forecasts growth trends (CAGR% - 2016 to 2020). The global disposable syringes market research report is further segmented by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World. The global disposable syringes market report also provides the detailed market landscape, market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. Major players operating in the global disposable syringes market and included in this report are B. Braun Melsungen AG, Becton, Dickinson & Company, Medtronic plc (Covidien plc), Codan Medizinische Geräte GmbH & Co. KG, Gerresheimer AG, Retractable Technologies, Inc., Smiths Medical, Star Syringe, Terumo Corporation, and Unilife Corporation. To request Table of Contents and Sample Pages of this report visit: https://www.ihealthcareanalyst.com/report/disposable-syringes-market/ About Us iHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals. In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study. Contact Us iHealthcareAnalyst, Inc. 2109, Mckelvey Hill Drive, Maryland Heights, MO 63043 United States Email: sales@ihealthcareanalyst.com Website: https://www.ihealthcareanalyst.com Maryland Heights, MO, February 17, 2017 --( PR.com )-- The global disposable syringes market to reach nearly USD 7.8 Billion in 2020, at a CAGR of 9.1% from 2016 to 2020, due to growth in injectable drugs and point-of-care administration worldwide.Browse Disposable Syringes Market by Syringe Types (Safety Syringes – Automatic Syringes and Manual Retractable Syringes, Non-Retractable Syringes; and Conventional Syringes – With or Without Needles) 2016-2020 report at https://www.ihealthcareanalyst.com/report/disposable-syringes-market/Globally, disposable syringes are more popular than re-usable syringes, primarily due to cost, accuracy, sterility, and ease of handling. Syringes equipped with safety mechanisms are known as safety syringes. Safety syringes protect patients and health care professionals from accidental needlestick injuries. Disposable Syringes with wide market potential are being used for intravenous or intramuscular injections and are fast replacing the age-old glass syringes due to their availability in sterilized condition, ready to use, and cost effectiveness. Disposable syringes are the most sold medical devices in the world. An estimated 39,000 million units are sold annually, with market value of approximately USD 4,935.8 million.The global disposable syringes market report provides market size estimates (Revenue USD million - 2013 to 2020) for key market segments based on the syringe type (safety syringes – automatic and manual retractable, non-retractable syringes; and conventional syringes either with or without needles), and forecasts growth trends (CAGR% - 2016 to 2020). The global disposable syringes market research report is further segmented by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World. The global disposable syringes market report also provides the detailed market landscape, market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments.Major players operating in the global disposable syringes market and included in this report are B. Braun Melsungen AG, Becton, Dickinson & Company, Medtronic plc (Covidien plc), Codan Medizinische Geräte GmbH & Co. KG, Gerresheimer AG, Retractable Technologies, Inc., Smiths Medical, Star Syringe, Terumo Corporation, and Unilife Corporation.To request Table of Contents and Sample Pages of this report visit: https://www.ihealthcareanalyst.com/report/disposable-syringes-market/About UsiHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study.Contact UsiHealthcareAnalyst, Inc.2109, Mckelvey Hill Drive,Maryland Heights, MO 63043United StatesEmail: sales@ihealthcareanalyst.comWebsite: https://www.ihealthcareanalyst.com Click here to view the list of recent Press Releases from iHealthcareAnalyst, Inc.


The global market for ampoule and syringes demonstrates a highly dynamic and competitive landscape, finds a new research report by Transparency market Research (TMR). The market has been largely dominated by Becton, Dickinson and Co., Gerresheimer AG, West Pharmaceuticals, Schott AG, and Nipro Corp., which collectively, held a share of nearly 77% in the overall market in 2015. Hitherto, these companies have been concentrating on making heavy investments in R&D activities; however, their focus is likely to shift towards constructing manufacturing facilities in high growth regions, such as India and China in the near future. Apart from this. Strategic alliance with leading regional participants will be another key focus area for these players over the next few years, states the research report. As per the research study, the global market for ampoules and syringes, which stood at US$5.1 bn in 2015, is likely to progress at an impressive CAGR of 10.50% during the period from 2016 to 2024, increasing the opportunity in this market to US$12.4 bn by the end of the period of the forecast. The demand for glass ampoules and glass syringes has been much higher than other products in this market and is expected to remain so over the years to come. An exhaustive study of the geographical segmentation of the worldwide ampoule and syringes market has also been included in this research study. According to the report, the worldwide market for ampoule and syringes stretches across Europe, the Middle East, and Africa (EMEA), Asia Pacific (APAC), Countries under the North American Free Trade Agreement (NAFTA), i.e., the U.S., Canada, and Mexico, and the Rest of the World. EMEA has been leading the global market over the last few years and is expected to retain its position throughout the forecast period. The presence of a state-of-art medical and healthcare infrastructure, increasing shift towards home healthcare, and the rising awareness among consumers regarding the benefits of ampoules and prefilled syringes in the region. Europe has emerged as the key contributor to the EMEA market for ampoule and syringes and is anticipated to remain seated in this position in the near future. The NAFTA ampoule and syringes market is also expected to witness healthy growth over the next few years, thanks to the presence of a large number of leading pharmaceutical companies in this region, notes the study. Increasing Trend of Home Healthcare to Influence Demand for Ampoules and Syringes "The substantial rise in the geriatric population suffering from various chronic diseases, together with the lower cost of progression-free survival (PFS) compared to hospitals or ambulatory service centers (ASCs) care, has augmented the trend of home healthcare, which is the main factor behind the growth of the ampoules and syringes market," says an analyst at TMR. As syringes ensure deliver precise dosages, helping patients self-administer the medicine without any formal medical training, their usage in home healthcare and point-of-care administration has increased significantly. In addition to this, with considerable advancements in the biologics and biosimilars market, the demand for ampoules and prefilled syringes is expected to increase remarkably over the forecast period. On the FLIP SIDE, the increasing product recalls due to breakages and leachables and the high cost associated with the temperature-controlled packaging needed for temperature-sensitive drugs may hamper the growth of this market to some extent in the near future, states the report. The study presented here is based on a report by Transparency Market Research (TMR) titled "Ampoules and Syringes Market (Ampoule Product Type - Glass Ampoules (Type I, Type II, and Type III), Plastic Ampoules (PVC, Polyethylene, Polypropylene, PET, EVA, and Polycarbonate), Cyclic Olefin Copolymers, and Cyclic Olefin Polymers; Syringe Product Type - Polymer Syringes (Cyclic Olefin Copolymers, Cyclic Olefin Polymers, and PP) and Glass Syringes) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2016-2024." The global ampoules and syringes market are segmented as follows Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge. Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR's syndicated reports strive to provide clients to serve their overall research requirement.


This report studies Sterilizable Syringes in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Sterilizable Syringes in these regions, from 2011 to 2021 (forecast), like North America Europe China Japan Southeast Asia India Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into Split by application, this report focuses on consumption, market share and growth rate of Sterilizable Syringes in each application, can be divided into View Full Report With Complete TOC, List Of Figure and Table: http://globalqyresearch.com/global-sterilizable-syringes-market-research-report-2016 Global Sterilizable Syringes Market Research Report 2016 1 Sterilizable Syringes Market Overview 1.1 Product Overview and Scope of Sterilizable Syringes 1.2 Sterilizable Syringes Segment by Type 1.2.1 Global Production Market Share of Sterilizable Syringes by Type in 2015 1.2.2 Type I 1.2.3 Type II 1.2.4 Type III 1.3 Sterilizable Syringes Segment by Application 1.3.1 Sterilizable Syringes Consumption Market Share by Application in 2015 1.3.2 Application 1 1.3.3 Application 2 1.3.4 Application 3 1.4 Sterilizable Syringes Market by Region 1.4.1 North America Status and Prospect (2011-2021) 1.4.2 Europe Status and Prospect (2011-2021) 1.4.3 China Status and Prospect (2011-2021) 1.4.4 Japan Status and Prospect (2011-2021) 1.4.5 Southeast Asia Status and Prospect (2011-2021) 1.4.6 India Status and Prospect (2011-2021) 1.5 Global Market Size (Value) of Sterilizable Syringes (2011-2021) 7 Global Sterilizable Syringes Manufacturers Profiles/Analysis 7.1 Becton, Dickinson and Company 7.1.1 Company Basic Information, Manufacturing Base and Its Competitors 7.1.2 Sterilizable Syringes Product Type, Application and Specification 7.1.2.1 Type I 7.1.2.2 Type II 7.1.3 Becton, Dickinson and Company Sterilizable Syringes Production, Revenue, Price and Gross Margin (2015 and 2016) 7.1.4 Main Business/Business Overview 7.2 B. Braun Melsungen AG 7.2.1 Company Basic Information, Manufacturing Base and Its Competitors 7.2.2 Sterilizable Syringes Product Type, Application and Specification 7.2.2.1 Type I 7.2.2.2 Type II 7.2.3 B. Braun Melsungen AG Sterilizable Syringes Production, Revenue, Price and Gross Margin (2015 and 2016) 7.2.4 Main Business/Business Overview 7.3 Gerresheimer AG 7.3.1 Company Basic Information, Manufacturing Base and Its Competitors 7.3.2 Sterilizable Syringes Product Type, Application and Specification 7.3.2.1 Type I 7.3.2.2 Type II 7.3.3 Gerresheimer AG Sterilizable Syringes Production, Revenue, Price and Gross Margin (2015 and 2016) 7.3.4 Main Business/Business Overview 7.4 Hindustan Syringes & Medical Devices Limited 7.4.1 Company Basic Information, Manufacturing Base and Its Competitors 7.4.2 Sterilizable Syringes Product Type, Application and Specification 7.4.2.1 Type I 7.4.2.2 Type II 7.4.3 Hindustan Syringes & Medical Devices Limited Sterilizable Syringes Production, Revenue, Price and Gross Margin (2015 and 2016) 7.4.4 Main Business/Business Overview 7.5 Terumo Corporation 7.5.1 Company Basic Information, Manufacturing Base and Its Competitors 7.5.2 Sterilizable Syringes Product Type, Application and Specification 7.5.2.1 Type I 7.5.2.2 Type II 7.5.3 Terumo Corporation Sterilizable Syringes Production, Revenue, Price and Gross Margin (2015 and 2016) 7.5.4 Main Business/Business Overview 7.6 Nipro Corporation 7.6.1 Company Basic Information, Manufacturing Base and Its Competitors 7.6.2 Sterilizable Syringes Product Type, Application and Specification 7.6.2.1 Type I 7.6.2.2 Type II 7.6.3 Nipro Corporation Sterilizable Syringes Production, Revenue, Price and Gross Margin (2015 and 2016) 7.6.4 Main Business/Business Overview 7.7 Schott AG 7.7.1 Company Basic Information, Manufacturing Base and Its Competitors 7.7.2 Sterilizable Syringes Product Type, Application and Specification 7.7.2.1 Type I 7.7.2.2 Type II 7.7.3 Schott AG Sterilizable Syringes Production, Revenue, Price and Gross Margin (2015 and 2016) 7.7.4 Main Business/Business Overview Global QYResearch is the one spot destination for all your research needs. Global QYResearch holds the repository of quality research reports from numerous publishers across the globe. Our inventory of research reports caters to various industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. With the complete information about the publishers and the industries they cater to for developing market research reports, we help our clients in making purchase decision by understanding their requirements and suggesting best possible collection matching their needs.


News Article | November 18, 2016
Site: www.newsmaker.com.au

Increasing production and consumption of wine, increasing demand for wine, increasing disposal income and changing preferences for alcoholic beverages are the drivers for global wine packaging market. However, high raw material costs are restraining the market growth. Glass bottle segment has the leading market for wine packaging. Due to its neutral and non reactive nature, glass bottle is most suitable material for wine packaging. Alternatives such as cans, plastic cups, plastic bottles and aseptic cartons are increasing their popularity due to appeal to younger consumers and product differentiation capability. Some of the significant market players include Vidrala, Consol Glass, Rexam, Bormioli Rocco, Vetropack Holding, Vitro Packaging, Saint-Gobain, Smufit Kappa, Wiegand-Glass, Hindusthan National Glass & Industries, Acor, Owens-Illinois, Koa Glass, Stolzle GlaSS, Ardagh, Victory Paper andPackaging, Piramal Glass, Brick Packaging, Scholle, and Gerresheimer. Regions Covered:  • North America  o US  o Canada  o Mexico  • Europe  o Germany  o France  o Italy  o UK  o Spain  o Rest of Europe  • Asia Pacific  o Japan  o China  o India  o Australia  o New Zealand  o Rest of Asia Pacific  • Rest of the World  o Middle East  o Brazil  o Argentina  o South Africa  o Egypt What our report offers:  - Market share assessments for the regional and country level segments  - Market share analysis of the top industry players  - Strategic recommendations for the new entrants  - Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets  - Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)  - Strategic recommendations in key business segments based on the market estimations  - Competitive landscaping mapping the key common trends  - Company profiling with detailed strategies, financials, and recent developments  - Supply chain trends mapping the latest technological advancements About Us Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.


Pharmaceutical Packaging is the packages used for medicine. It includes glass packaging, plastic packaging, aluminum foil packaging, and other pharmaceutical packaging. And applications of pharmaceuticals packaging are oral drugs, injectable and other areas. For more information or any query mail at sales@wiseguyreports.com This report focuses on the Pharmaceuticals Packaging in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Market Segment by Regions, regional analysis covers North America (USA, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, Korea, India and Southeast Asia) South America (Brazil, Argentina, Columbia etc.) Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Market Segment by Type, covers Plastic and Polymers Paper & Paperboard Glass Aluminum Foil Market Segment by Applications, can be divided into Oral Drugs Injectable Others 2 Manufacturers Profiles 2.1 Amcor 2.1.1 Business Overview 2.1.2 Pharmaceuticals Packaging Type and Applications 2.1.2.1 Type 1 2.1.2.2 Type 2 2.1.3 Amcor Pharmaceuticals Packaging Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.2 ACG 2.2.1 Business Overview 2.2.2 Pharmaceuticals Packaging Type and Applications 2.2.2.1 Type 1 2.2.2.2 Type 2 2.2.3 ACG Pharmaceuticals Packaging Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.3 Gerresheimer 2.3.1 Business Overview 2.3.2 Pharmaceuticals Packaging Type and Applications 2.3.2.1 Type 1 2.3.2.2 Type 2 2.3.3 Gerresheimer Pharmaceuticals Packaging Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.4 Schott 2.4.1 Business Overview 2.4.2 Pharmaceuticals Packaging Type and Applications 2.4.2.1 Type 1 2.4.2.2 Type 2 2.4.3 Schott Pharmaceuticals Packaging Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.5 DuPont? 2.5.1 Business Overview 2.5.2 Pharmaceuticals Packaging Type and Applications 2.5.2.1 Type 1 2.5.2.2 Type 2 2.5.3 DuPont? Pharmaceuticals Packaging Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.6 West-P 2.6.1 Business Overview 2.6.2 Pharmaceuticals Packaging Type and Applications 2.6.2.1 Type 1 2.6.2.2 Type 2 2.6.3 West-P Pharmaceuticals Packaging Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.7 Bilcare 2.7.1 Business Overview 2.7.2 Pharmaceuticals Packaging Type and Applications 2.7.2.1 Type 1 2.7.2.2 Type 2 2.7.3 Bilcare Pharmaceuticals Packaging Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.8 Nipro 2.8.1 Business Overview 2.8.2 Pharmaceuticals Packaging Type and Applications 2.8.2.1 Type 1 2.8.2.2 Type 2 2.8.3 Nipro Pharmaceuticals Packaging Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.9 AptarGroup 2.9.1 Business Overview 2.9.2 Pharmaceuticals Packaging Type and Applications 2.9.2.1 Type 1 2.9.2.2 Type 2 2.9.3 AptarGroup Pharmaceuticals Packaging Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.10 Svam Packaging 2.10.1 Business Overview 2.10.2 Pharmaceuticals Packaging Type and Applications 2.10.2.1 Type 1 2.10.2.2 Type 2 2.10.3 Svam Packaging Pharmaceuticals Packaging Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.11 Bemis Healthcare 2.11.1 Business Overview 2.11.2 Pharmaceuticals Packaging Type and Applications 2.11.2.1 Type 1 2.11.2.2 Type 2 2.11.3 Bemis Healthcare Pharmaceuticals Packaging Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.12 Datwyler 2.12.1 Business Overview 2.12.2 Pharmaceuticals Packaging Type and Applications 2.12.2.1 Type 1 2.12.2.2 Type 2 2.12.3 Datwyler Pharmaceuticals Packaging Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.13 NGPACK 2.13.1 Business Overview 2.13.2 Pharmaceuticals Packaging Type and Applications 2.13.2.1 Type 1 2.13.2.2 Type 2 2.13.3 NGPACK Pharmaceuticals Packaging Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.14 Jal Extrusion 2.14.1 Business Overview 2.14.2 Pharmaceuticals Packaging Type and Applications 2.14.2.1 Type 1 2.14.2.2 Type 2 2.14.3 Jal Extrusion Pharmaceuticals Packaging Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.15 SGD 2.15.1 Business Overview 2.15.2 Pharmaceuticals Packaging Type and Applications 2.15.2.1 Type 1 2.15.2.2 Type 2 2.15.3 SGD Pharmaceuticals Packaging Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 3 Global Pharmaceuticals Packaging Market Competition, by Manufacturer 3.1 Global Pharmaceuticals Packaging Sales and Market Share by Manufacturer 3.2 Global Pharmaceuticals Packaging Revenue and Market Share by Manufacturer 3.3 Market Concentration Rate 3.3.1 Top 3 Pharmaceuticals Packaging Manufacturer Market Share 3.3.2 Top 6 Pharmaceuticals Packaging Manufacturer Market Share 3.4 Market Competition Trend For more information or any query mail at sales@wiseguyreports.com ABOUT US: Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of rmaket research reports under these categories and sub-categories. For more information, please visit https://www.wiseguyreports.com


MARTINSRIED / MUNICH, Germany, Nov. 08, 2016 (GLOBE NEWSWIRE) -- Anke Linnartz has joined MorphoSys AG (Frankfurt: MOR; Prime Standard Segment, TecDAX, OTC: MPSYY) as Vice President and Head of Corporate Communications and Investor Relations effective November 1, 2016. Reporting to Chief Financial Officer Jens Holstein, she succeeds Dr. Claudia Gutjahr-Löser, who after serving MorphoSys for nearly 15 years will leave the Company at her own request at the end of November 2016 in order to take up new challenges. Anke Linnartz joins MorphoSys from Gerresheimer AG, a leading global partner to the pharma and healthcare industries listed in the German mid cap selection index M-Dax, where she headed the Investor Relations und Creditor Relations department from 2008 to 2016. Prior to that, she was in charge of the capital markets communications at German M-DAX company Demag Cranes AG. Before that, she headed the capital markets communications of GEA Group AG, managing the communications of a transformative group restructuring process. From 1998 to 2004, she worked in leading positions for German business intelligence company MIS AG. Anke Linnartz was member of the Board of Directors of the German Investor Relations Association (DIRK) for nine years. "We wish to thank Claudia Gutjahr-Löser for so many years of her outstanding commitment to MorphoSys and regret her departure. She has been instrumental in raising the profile of MorphoSys to today's high level and contributed considerably to the corporate success in the past 15 years", commented Jens Holstein, Chief Financial Officer of MorphoSys AG. "At the same time, we are extremely happy that we have gained with Anke Linnartz a highly experienced and competent capital markets expert as successor for this important corporate function in our company. We wish her a good start and every success in her new role at MorphoSys". About MorphoSys MorphoSys developed HuCAL, the most successful antibody library technology in the pharmaceutical industry. By successfully applying this and other patented technologies, MorphoSys has become a leader in the field of therapeutic antibodies, one of the fastest-growing drug classes in human healthcare. Together with its pharmaceutical partners, MorphoSys has built a therapeutic pipeline of more than 100 human antibody drug candidates for the treatment of cancer, rheumatoid arthritis, and Alzheimer's disease, to name just a few. With its ongoing commitment to new antibody technology and drug development, MorphoSys is focused on making the healthcare products of tomorrow. MorphoSys is listed on the Frankfurt Stock Exchange under the symbol MOR. For regular updates about MorphoSys, visit http://www.morphosys.com. HuCAL®, HuCAL GOLD®, HuCAL PLATINUM®, CysDisplay®, RapMAT®, arYla®, Ylanthia®, 100 billion high potentials®, Slonomics®, Lanthio Pharma® and LanthioPep® are registered trademarks of the MorphoSys Group. This communication contains certain forward-looking statements concerning the MorphoSys group of companies. The forward-looking statements contained herein represent the judgment of MorphoSys as of the date of this release and involve risks and uncertainties. Should actual conditions differ from the Company's assumptions, actual results and actions may differ from those anticipated. MorphoSys does not intend to update any of these forward-looking statements as far as the wording of the relevant press release is concerned. For more information, please contact: MorphoSys AG Anke Linnartz Head of Corporate Communications & IR


Global Sterile Medical Packaging market is accounted for $26.55 billion in 2015 and is expected to reach $42.85 billion by 2022 growing at a CAGR of 7.07%. Rising Adoption of Sterile packaging in packaging of medical equipment, pharmaceutical and biological products is one of the major factors driving the market. Factors such as rising healthcare awareness and disposable income are further fueling the market. However, maintaining medical packaging integrity is restricting the market growth. Pharmaceuticals and Biologics segment is expected to witness a highest share during the forecast period owing to its applications. North America accounted for the largest share in the market. Moreover, Asia Pacific is expected to witness the highest CAGR during the forecast period. The favourable growth is attributed to rising healthcare awareness and technological advancements. Some of the key players in global sterile medical packaging market include ALARIS Medical Systems, Honeywell International Incorporated, 3M Company, ESCO Technologies Incorporated, Becton, Dickinson and Company, Kimberly-Clark Corporation, Bemis Company Incorporated, Alcan Incorporated, Intercome Packaging Company Limited, Ethox Corporation, Abbott Laboratories, Gerresheimer Glass Inc., Baxter International Incorporated, Alcoa Incorporated, Unicep Packaging, Inc., and Amcor Limited. Products Covered: • Clamshell and Lids • Prefillable Syringes • Bottles • Vials and Ampoules o Pouches & Bags o Liner Tear Bags o Spout Pouches o Gusset Bags o Header Bags o Semi Ultra Clean Bags • IV Containers • Thermoform Trays • Other Products Regions Covered: • North America o US o Canada o Mexico • Europe o Germany o France o Italy o UK o Spain o Rest of Europe • Asia Pacific o Japan o China o India o Australia o New Zealand o Rest of Asia Pacific • Rest of the World o Middle East o Brazil o Argentina o South Africa o Egypt What our report offers: - Market share assessments for the regional and country level segments - Market share analysis of the top industry players - Strategic recommendations for the new entrants - Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets - Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations) - Strategic recommendations in key business segments based on the market estimations - Competitive landscaping mapping the key common trends - Company profiling with detailed strategies, financials, and recent developments - Supply chain trends mapping the latest technological advancements For more information, please visit https://www.wiseguyreports.com/sample-request/674322-sterile-medical-packaging-global-market-outlook-2016-2022


- Proposed dividend of EUR 1.05 per share (2015: EUR 0.85 per share) marks an increase of 23.5% - Revenues up 7.2% in financial year 2016 to EUR 1,375.5m - Adjusted EBITDA climbs to EUR 307.8m; at constant exchange rates to EUR 311.3m - Adjusted earnings per share after non-controlling interests increased from EUR 3.41 to EUR 4.22 - Focus on core business: sale of the Life Science Research Division completed as of October 31, 2016 Gerresheimer AG brought financial year 2016 to a successful close and sees strong growth prospects for the years ahead. Gerresheimer is one of the leading partners to the pharma and healthcare industry worldwide and manufactures glass and plastic pharma and cosmetics packaging. "2016 was a successful year for us. We delivered on our guidance for all key performance indicators and have grown substantially. Moreover, we further sharpened our focus on our core business. Going forward, we will continuously expand our development capabilities and product portfolio for the biotech and specialty pharma industry. In addition, we aim to further increase our profitability. The Company is ready for the challenges in the next years ahead," said Uwe Röhrhoff, CEO of Gerresheimer AG. As of October 31, 2016, Gerresheimer sold its Life Science Research Division-the laboratory glassware business. In accordance with International Financial Reporting Standards (IFRS), the division is therefore classified as a discontinued operation. In simple terms, from the time of classification as a discontinued operation, all income and expense items in the consolidated income statement are adjusted for the current year and retrospectively for all comparative periods to be reported upon and are shown in a separate item. Gerresheimer increased revenues in financial year 2016 (December 1, 2015 to November 30, 2016) by 7.2% to EUR 1,375.5m. On an organic basis, revenues went up by 2.9% to EUR 1,383.1m, within the target range of EUR 1,400m plus or minus EUR 25m. Notable revenue growth was generated with inhalers, plastic pharma packaging, injection vials and cosmetic glass. Adjusted EBITDA climbed in financial year 2016 to EUR 307.8m and at constant exchange rates to EUR 311.3m-at the upper end of the guidance range of EUR 305m plus or minus EUR 10m. The adjusted EBITDA margin was for the first time above the 22% mark, at 22.4% compared with a prior-year figure of 20.5%. Net income increased by 49.3% to EUR 168.2m, notably due to the sale of the Life Science Research Division. Adjusted earnings per share after non-controlling interests rose from EUR 3.41 to EUR 4.22. At 15.8% excluding the Life Science Research Division, average net working capital as a percentage of revenues likewise exceeded the Company's expectations. Net financial debt was scaled back by EUR 89.3m to EUR 788.2m, mainly due to the proceeds from the sale of the Life Science Research Division. Leverage, the ratio of net financial debt to adjusted EBITDA, was reduced from 2.9 to 2.6. Gerresheimer's capital expenditure in financial year 2016, at EUR 113.2m compared with EUR 125.8m in the prior year, corresponded to 8.2% of revenues at constant exchange rates excluding the Life Science Research Division. The Company continued to invest in standardizing and modernizing the machinery park in the glass segment. It also modernized the German cosmetic glass plant in Tettau and further expanded decorating capacity. Expansion continued at the Peachtree City plant in the USA, which produces medical plastic systems such as asthma inhalers. "We are optimistic for the future and continue to invest in key growth markets, even though the beginning of financial year 2016/17 appears to be more difficult than the start of the prior year. Our dividend proposal, representing a 23.5% increase to EUR 1.05 per share, reflects the significant improvement in our financial performance indicators," Uwe Röhrhoff added. Gerresheimer's expectations for financial year 2017 are set out in the following, in each case based on constant exchange rates. For the US dollar-which is expected to have the largest currency impact on the Group currency, accounting for about a third of Group revenues in 2017-Gerresheimer has assumed an exchange rate of approximately USD 1.10 to EUR 1.00. In financial year 2017, Gerresheimer anticipates Group revenues of around EUR 1.43bn (plus or minus EUR 25m) on a constant exchange rate basis, compared with EUR 1,375.5m in 2016. Adjusted EBITDA is expected to increase from EUR 308m in 2016 to some EUR 320m (plus or minus EUR 10m) in financial year 2017. Based on the improvement in adjusted EBITDA, adjusted earnings per share after non-controlling interests-the basis of Gerresheimer AG's dividend policy-is projected to rise to a figure in the range EUR 4.20 per share to EUR 4.55 per share (2016 adjusted for the discontinued operation comprising the Life Science Research Division: EUR 4.07 per share). Largely due to the favorable growth prospects and as a result of the initiatives to boost productivity and quality, capital expenditure in the financial year 2017 is expected to amount to around 8% of revenues at constant exchange rates. The Company's expectations through to the end of 2018 are as follows: At the Annual General Meeting on April 26, 2017, the Management Board and Supervisory Board will be jointly proposing that a dividend of EUR 1.05 per share be paid out for financial year 2016. This represents an increase of 23.5% against the prior-year dividend. The dividend ratio amounts to 24.9% of adjusted net income after non-controlling interests. The Annual Report is available here: http://www.gerresheimer.com/en/investor-relations/reports Corss reference: Full press release including table is available at: http://www.presseportal.de/nr/9072/dokument

Loading Gerresheimer collaborators
Loading Gerresheimer collaborators